Thermo Fisher, Immundiagnostik to Co-develop Mass Spec-based Assays
October 16, 2012
Thermo Fisher, Immundiagnostik to Co-develop Mass Spec-based Assays
Full-text access for registered users only.
Existing users login here.
New to GenomeWeb? Register here quickly for free access.
New to GenomeWeb? Register here quickly for free access.
Related Stories
- Matrix-Bio Licenses Metabolomic Biomarkers to Quest for Breast Cancer Test Development
April 11, 2013 / GenomeWeb Daily News - Thermo Fisher Inks Collaboration with University of Birmingham for Proteomic, Metabolomic Research
March 29, 2013 / GenomeWeb Daily News - Agilent, Sera Prognostics Team on Proteomic Assays
February 12, 2013 / GenomeWeb Daily News - Researchers Develop Seven-Second MRM-MS Workflow Using Agilent's RapidFire Technology
November 16, 2012 / ProteoMonitor - Immundiagnostik Deal Offers Thermo Fisher Chance to Highlight Immunoaffinity Mass Spec Workflows
October 26, 2012 / ProteoMonitor